Drug search by name

Carbidopa and Levodopa Extended-Release Tablets and Liver/renal

Result of checking the interaction of drug Carbidopa and Levodopa Extended-Release Tablets and disease Liver/renal for safety when used together.

Check result:

Carbidopa and Levodopa Extended-Release Tablets <> Liver/renal

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The pharmacokinetics of levodopa have not been studied in patients with hepatic or renal impairment. Therapy with levodopa should be administered cautiously in patients with liver or disease. Periodic monitoring of hepatic and renal function is recommended during extended therapy.

References:

"Product Information. Sinemet CR (carbidopa-levodopa)." Dupont Pharmaceuticals, Wilmington, DE.
"Product Information. Sinemet (carbidopa-levodopa)." DuPont Pharmaceuticals, Wilmington, DE.

Carbidopa and Levodopa Extended-Release Tablets

Generic Name: carbidopa / levodopa

Brand Name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa

Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa

What is Carbidopa and Levodopa Extended-Release Tablets?